Micrometastatic tumor detection in patients with head and neck cancer: A preliminary report

Archives of Otolaryngology - Head and Neck Surgery

Volumn 128, Issue 1, 2002, Pages 40-43

  Wirtschafter, Ari ^a   Benninger, Michael S ^a   Moss, Thomas J ^b   Umiel, Tehila ^c   Blazoff, Kathleen ^a   Worsham, Maria J ^a  

^a HENRY FORD HOSPITAL   (United States)

^b Clinical Protocol Development   (United States)

^c IMPATH/BIS Laboratories   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITHELIAL MEMBRANE ANTIGEN; MONOCLONAL ANTIBODY; TUMOR ANTIGEN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER STAGING; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; GLOTTIS; HEAD AND NECK CANCER; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METASTASIS; MOUTH CARCINOMA; OROPHARYNX CANCER; SQUAMOUS CELL CARCINOMA;

EID: 0036141128     PISSN: 08864470     EISSN: None     Source Type: Journal    
DOI: 10.1001/archotol.128.1.40     Document Type: Article

References (9)

1. Minimal residual disease in head and neck cancer
2. Head and neck cancer
3. Squamous cell carcinoma-associated antigens used in novel strategies for the detection and treatment of minimal residual head and neck cancer
4. Tumor enriched immunocytochemical (EICC) assay for the detection of circulating breast and prostate cancer cells in patients' peripheral blood (PB)
5. Mikerometastasen im knochenmark von patienten mit karzinomen des kopf-hals-bereiches
6. Immunocytologic detection of isolated tumor cells in bone marrow of patients with squamous cell carcinomas of the head and neck region
7. Haematogenous cytokeratin 20 mRNA as a predictive marker for recurrence in oral cancer patients
8. Prognostic value of immunocytologic detection of bone marrow metastases in neuroblastoma
9. Presence of circulating prostate cancer cells in peripheral blood (PB) of hormone refractory patients can be predictive of disease-free survival (DFS) and overall survival (OS)